Canada Pension Plan Investment Board bought a new stake in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) during the second quarter, HoldingsChannel.com reports. The fund bought 527,400 shares of the company’s stock, valued at approximately $254,745,000.
Several other large investors have also added to or reduced their stakes in ALAB. Eurizon Capital SGR S.p.A. bought a new position in shares of Astera Labs in the 4th quarter valued at about $18,708,000. Swedbank AB increased its stake in shares of Astera Labs by 76.8% during the 4th quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after purchasing an additional 33,940 shares during the last quarter. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. bought a new stake in shares of Astera Labs in the 4th quarter valued at about $499,000. Revere Asset Management Inc acquired a new stake in Astera Labs in the 4th quarter valued at about $589,000. Finally, Mitsubishi UFJ Trust & Banking Corp bought a new position in Astera Labs during the fourth quarter worth about $10,299,000. Institutional investors and hedge funds own 60.47% of the company’s stock.
Analyst Upgrades and Downgrades
ALAB has been the topic of several research analyst reports. Citigroup restated a “buy” rating on shares of Astera Labs in a research note on Wednesday, July 29th. Stifel Nicolaus boosted their target price on Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a report on Wednesday, June 24th. Royal Bank Of Canada increased their price target on Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a research note on Wednesday, August 5th. JPMorgan Chase & Co. raised their price target on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Finally, Rothschild & Co Redburn initiated coverage on shares of Astera Labs in a research report on Friday, May 1st. They set a “neutral” rating and a $153.00 price objective for the company. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $333.00.
Insider Activity at Astera Labs
In related news, Director Manuel Alba sold 136,974 shares of the business’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total value of $60,543,877.74. Following the completion of the sale, the director directly owned 1,287,524 shares in the company, valued at approximately $569,098,483.24. The trade was a 9.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of the stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $450.00, for a total value of $4,047,300.00. Following the sale, the director directly owned 4,631 shares in the company, valued at $2,083,950. This represents a 66.01% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 419,244 shares of company stock valued at $163,135,169. 10.40% of the stock is currently owned by company insiders.
Astera Labs Stock Performance
ALAB opened at $282.65 on Wednesday. The stock has a fifty day moving average of $348.88 and a 200-day moving average of $247.38. The company has a market capitalization of $49.04 billion, a P/E ratio of 139.93 and a beta of 3.84. Astera Labs, Inc. has a fifty-two week low of $97.89 and a fifty-two week high of $499.48.
Astera Labs (NASDAQ:ALAB – Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. During the same period last year, the firm earned $0.44 earnings per share. Astera Labs’s revenue for the quarter was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities research analysts predict that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.
Astera Labs Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Articles
- Five stocks we like better than Astera Labs
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
